m 20y old, oral fin 1mg daily, 5% min kirkland twice, 1.5 dermaroller every week
    Progress Pictures 8/2/2024

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily 3 months
    💧 Minoxidil (topical) 5% twice daily 3 months
    💧 dermaroller (topical) 1.5mm weekly 3 months
    the tone is 😀 positive with significant hair regrowth results.

    Other terms

    A 20-year-old male shared progress pictures after three months of using 1mg oral finasteride daily, 5% minoxidil twice daily, and a 1.5mm dermaroller weekly. He reported significant hair regrowth.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Evaluation of Efficacy of Intradermal Injection Therapy vs Derma Roller Application for Administration of QR678 Neo Hair Regrowth Formulation for the Treatment of Androgenetic Alopecia—A Prospective Study

      research Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo ® hair regrowth formulation for the treatment of Androgenetic Alopecia—A prospective study

      4 citations , April 2021 in “Journal of Cosmetic Dermatology”
      This study found that both intradermal injection and derma roller techniques for QR678Neo® hair regrowth therapy improved androgenetic alopecia symptoms, with intradermal injections showing non-significantly better video-microscopic outcomes but more pain and erythema associated with derma rollers.
      Transfollicular Drug Delivery: Current Perspectives

      research Transfollicular drug delivery: current perspectives

      10 citations , April 2016 in “Research and reports in transdermal drug delivery”
      This review discusses the potential of follicular drug delivery systems to target the pilosebaceous unit and reports no new research findings.
      Combination and Rotational Therapy in Androgenetic Alopecia

      research Combination and rotational therapy in androgenetic alopecia

      April 2023 in “Journal of Cutaneous and Aesthetic Surgery”
      This review proposes a combination treatment scheme with a rotational approach for managing androgenetic alopecia, drawing on evidence for effectiveness, long-term use convenience, and patient acceptance, but presents no new clinical results.

      research Oral Presentations

      July 2012 in “International Journal of Trichology”
      This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      Hair Loss in Men and Women: Medical and Surgical Treatments for Androgenic Alopecia

      research Hair Loss in Men and Women

      April 2019 in “Advances in Cosmetic Surgery”
      The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.